Company
Sapreme Technologies
Next-generation RNA therapeutics through engineered endosomal escape
Also known as Sapreme, Sapreme Therapeutics B.V.
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
- Customers
- select pharma/biotech companies
- Legal name
- Sapreme Therapeutics B.V.
Claim, correct or request removal
Record updated 21 September 2026
About
Sapreme is a preclinical-stage biotech company developing next-generation RNA therapeutics for patients with genetically driven diseases. Our proprietary endosomal escape technology enables targeted delivery of large molecules such as ASOs and siRNAs to intracellular targets in liver and extrahepatic tissues, such as muscle, heart and the brain.
Loading relationship preview